COVID-19 Vaccine Availability for Fall 2026
Based on the most current evidence, there is NO information available about COVID-19 vaccines specifically for the fall of 2026. The most recent guideline evidence addresses the 2024-2025 vaccine season, with the latest formulations approved in August 2024 1.
What We Know About Current Vaccine Timelines
The available evidence only extends through:
- 2024-2025 season: FDA-approved vaccines from Moderna and Pfizer-BioNTech (targeting KP.2 strain) and Novavax (targeting JN.1 strain) were authorized in August 2024 1
- 2025 adult immunization schedule: Published in January 2025, referencing the 2024-2025 vaccine formulations 2
Research Evidence from 2026 Studies
Interestingly, several research studies dated 2026 reference a "2025-2026 COVID-19 vaccine" targeting JN.1 and LP.8.1 lineages that reportedly became available in September 2025 3, 4, 5, 6, 7. These studies describe:
- Updated formulations targeting the LP.8.1 lineage 3
- Vaccines available starting September 2025 4
- FDA-approved vaccines including Pfizer-BioNTech's Comirnaty® LP.8.1, Moderna's Spikevax LP.8.1, and Novavax's Nuvaxovid LP.8.1 5
However, these appear to be research projections or modeling studies rather than official guideline recommendations, as no ACIP or CDC guidelines from 2025-2026 are present in the evidence base.
Important Caveats
- No official 2026 guidance exists in the provided evidence
- The pattern suggests annual vaccine updates will likely continue, with new formulations typically released in late summer/early fall
- ACIP continues to evaluate emerging evidence and updates recommendations as new variants emerge 1
For fall 2026 vaccine information, you would need to consult CDC/ACIP guidance that will be released closer to that time period, likely in summer 2026 based on historical patterns.